206 related articles for article (PubMed ID: 34412918)
21. Reshaping the tumor microenvironment: extracellular vesicles as messengers of cancer cells.
Bhatta B; Cooks T
Carcinogenesis; 2020 Nov; 41(11):1461-1470. PubMed ID: 33047121
[TBL] [Abstract][Full Text] [Related]
22. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
24. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells.
Mu Q; Najafi M
Int Immunopharmacol; 2021 Sep; 98():107895. PubMed ID: 34171623
[TBL] [Abstract][Full Text] [Related]
26. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.
Mun JY; Leem SH; Lee JH; Kim HS
Front Immunol; 2022; 13():864739. PubMed ID: 35464435
[TBL] [Abstract][Full Text] [Related]
27. Role of miRNAs in cell signaling of cancer associated fibroblasts.
Eichelmann AK; Matuszcak C; Hummel R; Haier J
Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
29. Stromal regulation of tumor-associated lymphatics.
Munir H; Mazzaglia C; Shields JD
Adv Drug Deliv Rev; 2020; 161-162():75-89. PubMed ID: 32783989
[TBL] [Abstract][Full Text] [Related]
30. Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review).
Guo Y; Shen R; Yu L; Zheng X; Cui R; Song Y; Wang D
Oncol Rep; 2020 Nov; 44(5):1799-1809. PubMed ID: 33000284
[TBL] [Abstract][Full Text] [Related]
31. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Agresta L; Hoebe KHN; Janssen EM
Front Immunol; 2018; 9():2809. PubMed ID: 30546369
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
33. Growth differentiation factor 15 and its role in carcinogenesis: an update.
Modi A; Dwivedi S; Roy D; Khokhar M; Purohit P; Vishnoi J; Pareek P; Sharma S; Sharma P; Misra S
Growth Factors; 2019 Aug; 37(3-4):190-207. PubMed ID: 31693861
[TBL] [Abstract][Full Text] [Related]
34. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
Zhao H; Wei J; Sun J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
36. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
Pachynski RK; Wang P; Salazar N; Zheng Y; Nease L; Rosalez J; Leong WI; Virdi G; Rennier K; Shin WJ; Nguyen V; Butcher EC; Zabel BA
Front Immunol; 2019; 10():983. PubMed ID: 31139180
[TBL] [Abstract][Full Text] [Related]
37. Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Pansy K; Uhl B; Krstic J; Szmyra M; Fechter K; Santiso A; Thüminger L; Greinix H; Kargl J; Prochazka K; Feichtinger J; Deutsch AJ
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948104
[TBL] [Abstract][Full Text] [Related]
38. Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.
Wei G; Zhang H; Zhao H; Wang J; Wu N; Li L; Wu J; Zhang D
Cancer Lett; 2021 Jul; 511():68-76. PubMed ID: 33957184
[TBL] [Abstract][Full Text] [Related]
39. Classification and biology of tumour associated stromal cells.
Raffaghello L; Dazzi F
Immunol Lett; 2015 Dec; 168(2):175-82. PubMed ID: 26145459
[TBL] [Abstract][Full Text] [Related]
40. Stromal reprogramming: A target for tumor therapy.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]